NGNE – neurogene inc. (US:NASDAQ)
Stock Stats
News
Neurogene (NGNE) is now covered by Guggenheim. They set a "buy" rating on the stock.
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy [Yahoo! Finance]
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors [Yahoo! Finance]
Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors
Form 3 Neurogene Inc. For: Apr 20 Filed by: Shafer Christina
Form 8-K Neurogene Inc. For: Apr 20
Form ARS Neurogene Inc. For: Dec 31
Form DEFA14A Neurogene Inc.
Form DEF 14A Neurogene Inc. For: Jun 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.